Skip to content

MCE for Gastric Examination in Obese People

A Retrospective Study to Evaluate the Feasibility and Safety of Magnetically Controlled Capsule Endoscope System in Gastric Examination in Obese People

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05909124
Enrollment
300
Registered
2023-06-18
Start date
2023-06-30
Completion date
2023-10-31
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

This retrospective study aimed to evaluate the feasibility and safety of MCE for the detection of gastric disease in obese people.

Detailed description

In this study, we evaluated the feasibility and safety of MCE for the detection of gastric disease in obese people by comparing the results of MCE between healthy weight people (18.5≤BMI\<25) and obese people (BMI≥30). The observation index included mucosal visualization, gastric transit time, cleanliness of the stomach, detection of lesions and safety evaluation.

Interventions

DEVICEMCE

underwent MCE examination

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* 18.5≤BMI\<25 or BMI≥30 * underwent gastric examination; * At least 18 years old; * Be able to provide informed consent.

Exclusion criteria

* With swallowing obstruction or disorders; * With known or suspected gastrointestinal obstruction, stenosis and fistula; * Have no conditions for surgery or refuse to undergo any abdominal surgery; * Be allergic to or have other known contraindication or intolerance to the drug used in the study; * With pacemakers or other electronic devices such as electronic cochlear implants, implanted magnetic metal drug infusion pumps, neurostimulators, and magnetic metal foreign bodies; * Women during pregnancy; * Currently enrolled in another clinical trial of a drug or device; * Other conditions determined by the investigator to be inappropriate for enrollment.

Design outcomes

Primary

MeasureTime frameDescription
the degree of gastric mucosal visualization2 weeksThe overall observational integrity of the gastric mucosa is based on the evaluation of the mucosal visualization of several key anatomical sites in the stomach: cardia, fundus, gastric body, gastric horn, gastric antrum and pylorus. The evaluation criteria for mucosal visualization of each site are: good : adequate observation, ≥90% of the gastric mucosa can be observed; fair : good observation, 70-90% of the gastric mucosa can be observed; poor : inadequate observation, \<70% of the gastric mucosa can be observed.

Secondary

MeasureTime frameDescription
the cleanliness of the stomach2 weeksThe criteria for judging the cleanliness of the stomach are: excellent : no adhesive mucus and foam, clear field of view; good : a small amount of mucus and foam, but the field of view is not blurred and does not affect the integrity of the examination; average : medium amount of mucus and foam, the field of view is more blurred and affects the integrity of the examination; poor : a large amount of mucus and foam, the field of view is blurred and affects the integrity of the examination.
Stomach transmit time2 weeksThe time of the first stomach image, the first small intestine image and the last image taken by capsule endoscopy were recorded. Stomach transmit time: time of first small intestine image minus time of first stomach image.
Small bowel transmit time2 weeksThe time of the first large intestine image minus the time of the first small intestine image.
Incidence of adverse events2 weeksThe rates of adverse events such as asphyxia by capsule aspiration, swallow disorder, retention, technical failure, and procedural adverse events were recorded.
Gastric distention2 weeksAssess condition of gastric distention. The criteria for judging gastric distention is: excellent, no obvious gastric folds; good, moderate distance between gastric folds, without folding; fair, short distance between gastric folds, with small amount of folding; poor, no obvious distance between gastric folds, with large amount of folding

Countries

China

Contacts

Primary ContactZhuan Liao
liaozhuan@smmu.edu.cn86-21-31161004

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026